View Older Stories

Jul 27, 2026 12:15PM TD Cowen reports short interest changes in life science stocks

Jul 1, 2026 08:38AM Illumina (ILMN) PT Raised to $200 at Piper Sandler

Jun 26, 2026 06:11AM Bernstein SocGen Group Resumes Illumina (ILMN) at Market Perform

Jun 10, 2026 05:49AM JPMorgan Upgrades Illumina (ILMN) to Overweight

Jun 8, 2026 09:15AM Illumina launches StrataMap spatial research solution

Jun 1, 2026 08:59AM IDT partners with Illumina for oncology research workflows

Jun 1, 2026 07:20AM Illumina (ILMN) PT Raised to $180 at Guggenheim

May 28, 2026 12:45PM Illumina partners with SPT Labtech to launch fireflyGO automation platform

May 28, 2026 09:16AM Illumina launches whole-genome sequencing kit for cancer research

May 14, 2026 04:24PM RBC Capital Assumes Illumina (ILMN) at Outperform

May 14, 2026 03:24AM Daiwa Securities Upgrades Illumina (ILMN) to Outperform (2)

May 1, 2026 10:41AM Illumina (ILMN) PT Raised to $100 at BofA Securities

May 1, 2026 06:49AM Illumina (ILMN) PT Lowered to $140 at Canaccord

May 1, 2026 04:14AM Illumina (ILMN) PT Raised to $155 at Evercore ISI

Apr 30, 2026 04:15PM Illumina (ILMN) Tops Q1 EPS by 9c; offers guidance

Apr 28, 2026 09:18AM Barclays: Life science insiders sold $187M in stock during first quarter

Mar 26, 2026 07:27AM Illumina (ILMN) PT Raised to $145 at Argus

Mar 23, 2026 05:57AM Canaccord Reiterates Hold Rating on Illumina (ILMN)

Mar 18, 2026 09:15AM Illumina and Labcorp expand precision oncology testing collaboration

Mar 16, 2026 09:15AM Illumina forms consortium with Veritas Genetics for preventive genomics

Feb 27, 2026 09:20AM Illumina partners with Florida State University for rare disease testing

Feb 26, 2026 04:06PM Evercore ISI: 'We believe ILMN shares are set for a relief rally'

Feb 26, 2026 02:28PM Wolfe: 'Roche Consumables Priced at $150/genome, Though There Are Some Nuances/Limits?; Launch Mid-2026'

Feb 26, 2026 01:29PM Canaccord: 'Roche ups the ante with $150 genome and reusable chips (20x); may prove formidable vs. ILMN; HOLD'

Feb 25, 2026 09:18AM Illumina announces cancer research advances using multiomics technologies

Feb 24, 2026 12:32PM Illumina launches TruPath Genome sequencing technology

Feb 23, 2026 09:15AM Illumina announces NovaSeq X system upgrades over 18 months

Feb 6, 2026 10:01AM Stifel Reiterates Buy Rating on Illumina (ILMN)

Feb 6, 2026 06:28AM Canaccord Genuity Reiterates Hold Rating on Illumina (ILMN)

Feb 6, 2026 05:58AM Canaccord Genuity Reiterates Hold Rating on Illumina (ILMN)

Feb 5, 2026 04:16PM Illumina (ILMN) Tops Q4 EPS by 13c, provides guidance

Jan 26, 2026 05:15AM Illumina (ILMN) PT Raised to $150 at Canaccord Genuity

Jan 20, 2026 09:15AM Illumina receives CMS reimbursement for cancer genomic test

Jan 20, 2026 06:26AM Illumina (ILMN) PT Raised to $155 at Stifel

Jan 13, 2026 09:15AM Illumina launches billion cell dataset for drug discovery AI

Jan 13, 2026 09:03AM Illumina reports preliminary Q4 revenue of $1.16 billion, up 5%

Jan 6, 2026 09:15AM Illumina launches cloud-based multiomic research software platform

Dec 10, 2025 08:06AM Illumina (ILMN) Sees Multiple Growth Levers Over 3-5 Years - Stifel

Nov 12, 2025 12:00PM Illumina study finds whole-genome sequencing captures 90% of genetic signals

Nov 10, 2025 12:22PM Illumina reports 40 customers using protein prep solution across 16 sites

Nov 5, 2025 05:17PM China lifts export ban on Illumina effective November 10

Oct 31, 2025 03:32AM Illumina (ILMN) PT Raised to $112 at Canaccord Genuity

Oct 30, 2025 04:31PM Illumina (ILMN) Tops Q3 EPS by 17c; offers guidance

Oct 16, 2025 06:39AM Guggenheim Reiterates Buy Rating on Illumina (ILMN)

Oct 15, 2025 09:16AM Illumina constellation technology identifies hard-to-detect genetic variants

Oct 15, 2025 09:16AM Illumina launches 5-base solution for genomic and epigenomic analysis

Oct 14, 2025 01:42PM Illumina (ILMN) 2100 contracts of October 90 puts trade, share price down 4.2%

Oct 1, 2025 09:05AM Illumina launches BioInsight business for data and AI solutions

Oct 1, 2025 08:00AM BofA introduces Top 10 U.S. ideas for Q4 2025

Sep 23, 2025 09:15AM Illumina partners with pharma companies on KRAS cancer diagnostics

View Older Stories